Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Sage Therapeutics Inc. (SAGE)

130.74   -6.55 (-4.77%) 01-23 16:00
Open: 134.81 Pre. Close: 137.29
High: 139.99 Low: 127.16
Volume: 633,114 Market Cap: 6130M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 140.134 - 140.899 140.899 - 141.534
Low: 125.427 - 126.318 126.318 - 127.058
Close: 129.367 - 130.757 130.757 - 131.913

Technical analysis

as of: 2019-01-23 4:31:03 PM
Overall:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. It is relatively safe to short or sell, downward move is expected.
Target: Six months: 185.23     One year: 216.35
Support: Support1: 109.95    Support2: 79.88
Resistance: Resistance1: 158.59    Resistance2: 185.23
Pivot: 123.65
Moving Average: MA(5): 135.98     MA(20): 115.00
MA(100): 124.17     MA(250): 145.92
MACD: MACD(12,26): 8.77     Signal(9): 6.37
Stochastic oscillator: %K(14,3): 68.80     %D(3): 70.66
RSI: RSI(14): 58.76
52-week: High: 195.97  Low: 79.88  Change(%): -27.5
Average Vol(K): 3-Month: 60669  10-Days: 79178

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
SAGE has closed below upper band by 39.4%. Bollinger Bands are 112% wider than normal. The large width of the bands suggest high volatility as compared to SAGE's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

2019-01-23T14:05:04-05:00
Jefferies bearish on biotechs, sees 6% near-term downside

2019-01-23T07:00:00-05:00
Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors

2019-01-23T05:03:00-05:00
Fundsmith Equity Fund Annual Letter To Shareholders 2018

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 46.89
Shares Float (M) 45.63
% Held by Insiders
% Held by Institutions 175.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -6.420
EPS Est. Current Year -7.400
EPS Est. Next Year -7.690
EPS Est. Next Quarter -2.000
Forward EPS -8.108
Book Value (p.s.) 6.470
PEG Ratio -1.37
Profit Margin
Operating Margin -332.73
Return on Assets (ttm) -43.8
Return on Equity (ttm) -47.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -217.79
Levered Free Cash Flow (M) -117.47

Stock Valuations

P/E -20.36
P/E Growth Ratio -0.05
P/BV 20.21
P/S 3034850816.00
P/CF -28.15

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.